Objective: In children with acute CNS infection, management of raised intracranial pressure improves mortality and neuromorbidity. We compared cerebral perfusion pressure-targeted approach with the conventional intracranial pressure-targeted approach to treat raised intracranial pressure in these children.
high mortality and neurodisability in children (1) (2) (3) . Raised ICP was seen in 69% of patients with viral encephalitis and 86% of patients with bacterial meningitis, especially in children with a coma score 8 or less (4, 5) . In our PICU, raised ICP was diagnosed in 44% of children with acute CNS infections, mainly during first 2-3 days of illness (6, 7) . In Japanese encephalitis, among patients with raised ICP (cerebrospinal fluid opening pressure ≥ 25 cm) 46% died; among those with poor outcome, 70% had signs of herniation syndromes (3) . In bacterial meningitis, 39% of mortality related to neurologic factors occurred within an average of 16.5 hours after hospitalization despite proper antibiotics administration (8) ; cerebral herniation was seen in 30% on autopsy study (9) . In developing regions of Africa and Southeast Asia, fatality rates and neurologic sequelae among survivors of the disease can be as high as 50% (10, 11) and twice as high as those among survivors in the European region (12) .
Raised ICP in acute meningitis results from several possible reasons, such as occlusion of arachnoid granulations, constriction and strangulation of cerebral veins, cerebritis and adhesion formation at the base of the brain, and an increase in cerebrospinal fluid production, but diffuse inflammatory edema is a major contributory factor (13) . In acute viral encephalitis, raised ICP results from brainstem involvement, along with cytotoxic brain edema in the early stage, followed by vasogenic and osmotic brain edema in the later stages (5) . In bacterial meningitis, elevated ICP is associated with impaired cerebral blood flow in the first 2 days of illness; resolution of intracranial hypertension is associated with 80% improvement in cerebral blood flow (14) . ICP monitoring can substantially influence clinical management and outcome in comatose children (15) . Continuous monitoring of ICP can enable rapid diagnosis and initiation of treatment when cerebral perfusion pressure (CPP) is reduced to critical levels (5) . Benefit of ICP monitoring in herpes encephalitis, postinfectious encephalitis with severe status epilepticus (4) , and CNS infections of various etiologies has been well documented (16, 17) . ICP monitoring is recommended in management of traumatic brain injury (TBI) and is accepted as a relatively low risk, high yield intervention (18) .
There is a general consensus that an ICP more than 20 mm Hg should be treated (4, 5, (19) (20) (21) . There is some rationale for treating smaller elevations (> 15 mm Hg) to avoid larger elevations that can cause cerebral herniation and irreversible brainstem injury (5, 22) . Reducing raised ICP above 15 mm Hg increased the survival in children with bacterial meningitis (21) . Conventional treatment of raised ICP targets control of cerebral edema with osmotic agents, mainly mannitol. Osmotherapy, particularly mannitol, can cause unpredictable diuresis, hypovolemia, hypotension and hypoperfusion, a rebound increase in ICP, and a decrease in CPP, and therefore, its use for treatment has been questioned (23) . Hypotension can worsen neurologic outcome, as has been shown in pediatric TBI patients (24) . In our unit, use of mannitol was associated with three times higher mortality (10 of 32, 31% patients) in patients with bacterial meningitis as compared with those who did not receive mannitol (10 of 112, 8.9%), especially when it was accompanied by excessive diuresis (S. Singhi, unpublished data, 2008) .
Over the years, treatment of raised ICP by optimizing CPP has gained recognition as the therapeutic modality in children and adult (17, 25, 26) . Feasibility of a CPP-targeted approach was demonstrated in children with raised ICP due to TBI (27) and acute CNS infections (7) . However, there is no published randomized controlled study comparing CPP-and ICP-targeted treatment of raised ICP in children with acute CNS infections till date. We have compared effect of CPP-and ICP-targeted management of raised ICP on mortality and neurodisability in children with acute CNS infections. Our hypothesis was that CPP-targeted therapy should be associated with lower mortality and neurodisability as compared with traditional ICP-targeted approach.
MATERIALS AND METHODS

Study Design and Subjects
This was an open-label randomized trial conducted in the PICU of a multispecialty, tertiary care, teaching hospital in India. Hundred ten children with acute CNS infections admitted from July 2007 to December 2010 were enrolled consecutively. Inclusion criteria were 1) age 1-12 years, 2) modified Glasgow Coma Scale score (m-GCS) less than or equal to 8 (28) , and 3) evidence of raised ICP-either clinical or on neuroimaging. Clinical signs included changes in heart rate (tachycardia or bradycardia), hyperventilation, tonic posturing, unequal pupils, brisk deep tendon reflex, extensor plantar, and papilledema or brain herniation syndromes. Signs considered suggestive on CT were loss of sulci, slit-like ventricle, loss of gray-white distinction, and obliteration of suprasellar and quadrigeminal cistern (29) . Patients with unstable hemodynamic, TBI, subarachnoid hemorrhage, epidural or subdural hematoma, hydrocephalus, CNS tumors, hypertensive encephalopathy, coagulopathy, infection at the site of insertion, subdural and epidural infection, neurodevelopmental delay or chronic neurologic illness, and clinical brain death were excluded. Patients with history of illness more than 7 days were excluded to ensure that chronic CNS infection particularly tuberculosis, which is not uncommon in our patient population, is excluded (30) . Malaria was excluded at the time of hospital arrival by rapid diagnostic test (card test) and smear examination. Written informed consent was obtained from parents or legal guardian. The institute ethics committee had approved the study.
Definitions
A diagnosis of acute CNS infection was considered in presence of fever and CNS dysfunction (irritability, lethargy, impaired consciousness or coma, and signs of meningeal irritation). Bacterial meningitis was diagnosed if patients additionally had any of the following: 1) CSF showing bacteria on culture or Gram stain or bacterial antigen; 2) positive blood culture plus CSF showing > 5 leukocytes/mm 3 , glucose ≤ 40 mg/dL or CSF/ serum glucose ratio ≤ 0.5, protein ≥ 100 mg/dL; 3) any three of the following changes-CSF showing ≥ 100 leukocytes/mm 3 (predominantly polymorphonuclear), CSF glucose ≤ 40 mg/dL or CSF/serum glucose ratio ≤ 0.5, CSF protein ≥ 100 mg/dL, and serum C-reactive protein ≥ 40 mg/dL (along with a negative tuberculin test and chest radiograph negative for pulmonary tuberculosis). In most of our patients, lumbar tap for CSF examination was done 1-2 days after enrollment-once initial control of the raised ICP was achieved. Hence, we used a more liberal definition (31) .
Encephalitis was defined as presence of signs of an inflammatory process of the brain (fever and CSF showing lymphocytic pleocytosis and protein > 40 mg/dL) in association with clinical evidence of diffuse cerebral dysfunction or focal neurologic deficit in absence of an alternative diagnosis (31, 32) . Etiological diagnosis was made on basis of microbiological evidence of specific virus (Japanese, Herpes simplex by CSF micro enzyme-linked immunosorbent assay or polymerase chain reaction) or mycoplasma serology or radiological evidence (31) (32) (33) .
Randomization and Masking
Patients were randomized into two groups (n = 55 each) by block randomization with variable size blocks (34) . A computer-generated randomization list was generated by a person not directly involved with data collection, analysis, or interpretation. Individual assignments were placed in serially numbered, sealed, opaque envelopes. Patients were enrolled sequentially, and envelopes were opened only after obtaining written consent for enrollment. The intervention arms were not masked because of nature of study; however, the statistician was blinded to treatment assessment till initial analysis and preparation of first draft.
Intervention
In ICP group, an ICP less than 20 mm Hg was targeted by using osmotic diuretics (20% mannitol; 0.25-1 g/kg/dose and/ or 3% saline 10 mL/kg loading followed by 0.1-1 mL/kg/hr) (35, 36) and deep sedation, if needed. Fluid bolus and vasoactive agents were used if blood pressure was less than fifth percentile. In CPP group, a CPP more than or equal to 60 mm Hg was targeted using normal saline bolus and vasoactive drugs (dopamine 10-20 μg/kg/min, and if needed noradrenaline, 0.05-0.4 μg/kg/min). If CPP was still less than 60 mm Hg and systolic blood pressure more than 95th percentile, they were treated with osmotherapy, and if needed, deep sedation was given. Acute spikes of raised ICP in both the groups were treated with short-term hyperventilation and/or osmotherapy ( Appendix 1, Supplemental Digital Content 1, http://links. lww.com/CCM/A893). 
ICP Monitoring
General Care and Monitoring
Standard care including head position in midline at 30°, sedation, analgesia, control of fever and seizures, maintenance of normoxia, and normocarbia was given to children in both the groups (Appendix 2, Supplemental Digital Content 2, http:// links.lww.com/CCM/A894). All children were monitored continuously in the PICU by a team of trained physicians and nurses.
Follow-Up
Survivors were followed up at 90 days after discharge for a complete neurologic examination and evaluation of functional status using Pediatric Cerebral Performance Category (PCPC) scale (37) and hearing deficit by brainstem-evoked response audiometry (40, 60, 90 db) or pure tone audiometry. Functional status was evaluated by the first author and an examiner who was unaware of protocol assignment under supervision of a pediatric neurologist. Patients were categorized based on cerebral performance as normal (score 1: normal at age-appropriate level; school-age child attending regular school classroom), mild neurodisability (score 2: conscious, alert, and able to interact at age-appropriate level, but grade not appropriate for age due to mild neurologic deficit), moderate neurodisability (score 3: conscious, sufficient cerebral function for age-appropriate independent activities of daily life, school-age child attending special education classroom and/or learning deficit present), severe neurodisability (score 4: conscious, dependent on others for daily support because of impaired brain function), and coma or vegetative state (score 5: any degree of coma without the presence of all brain death criteria).
Outcome Measures
Primary outcome: Mortality from enrollment up to 90 days after discharge from PICU (90-day mortality). Secondary outcome: 1) m-GCS score at 72 hours after enrollment, 2) length of PICU stay and of mechanical ventilation, and 3) hearing deficit and functional neurodisability (assessed as functional status on PCPC scale) at the time of discharge from PICU and at 90 days after discharge.
Sample Size
Mortality in comatose children (m-GCS score ≤ 8) with acute CNS infections in our unit was 45% (38) . We, therefore, assumed that CPP-targeted therapy may bring the mortality down to 20%, that is, an absolute risk reduction of 25% (45-25% = 20%) (7) . Assuming a two-sided α level of 0.05 and 80% power, 54 patients were needed in each group (http:// www.stat.ubc.ca/~rollin/stats/ssize/b2.html). 
Statistical Analysis
Complete set of data was available for analysis of primary outcomes and secondary outcomes. Data of all the patients were analyzed according to their assigned group (intention to treat) and summarized as means with ± sd or ± sem, medians with interquartile ranges, or proportions. Normality of data was checked with Kolmogorov-Smirnov Z test. Normally distributed data were compared by Student t test, nonnormally distributed data with the use of the Mann-Whitney U test, and proportions with the use of the chi-square test (Fisher exact test if cell frequencies were small). Relationship between MABP and ICP was examined with Pearson product moment correlation analysis. General linear model-repeated measures analysis of variance (RM-ANOVA) was used for determining the trend of MABP, ICP, CPP, m-GCS score, and vasoactive score over 72 hours between the groups. Data of 12 patients (six in ICP group and six in CPP group) that were incomplete ICP due to death (n = 11) or surgical procedure were missed only in RM-ANOVA analysis. Kaplan-Meier and log-rank tests were used for analysis of "time to event" data (death, time to PICU discharge, resolution of coma and mechanical ventilation, ICP catheter removal), followed by Cox regression analysis to adjust for prespecified baseline factors (age, sex, diagnosis). All tests were two-tailed and a p value of less than 0.05 was taken as significant. SPSS 20.0 software (SPSS, Chicago, IL) and Epi Info 7 (7.0.9.7; Centers for Disease Control and Prevention, Atlanta, GA) were used for data analysis.
RESULTS
Study Participants
Patients were recruited from July 2007 to December 2010; the last follow-up visit (90 d after PCIU discharge) was in April 2011. The trial ended when the planned sample size was attained. A total of 261 children were screened; 110 were enrolled in the study (Fig. 1) . No protocol violation was noted. The two study groups were similar with regard to all baseline characteristics ( Table 1) . Pupillary reaction to light was present in all. Acute viral encephalitis (68, 61.8%) was the most common diagnosis; 42 (38.2%) had acute meningitis (Table 1) .
Eleven 
Clinical Outcomes
Mortality during PICU stay (RR = 2.0; 95% CI, 1.03-3.87; p = 0.032) and total mortality up to 90 days after discharge (RR = 2.1; 95% CI, 1.09-4.04; p = 0.020) was significantly higher in the ICP group as compared with CPP group (Table 3 and Fig. 2 ). In the ICP group, 15 of 20 deaths were attributed to refractory raised ICP in contrast to 5 of 10 deaths in CPP group. Subgroup analysis by type of acute CNS infection showed significant differences in 90-day mortality between groups for children with Median m-GCS scores at 24, 48, and 72 hours after enrollment, at the time of removal of ICP catheter, and discharge from PICU were significantly higher in CPP group ( Table 4) . Proportion of patients with m-GCS score more than or equal to 9 at all the above time points was also significantly higher in CPP group (Fig. 3) . On Kaplan-Meier analysis, median (95% CI) duration of coma was lower by 2 days in CPP group than that in ICP group (Fig. 4A) ; median length of PICU stay (Fig. 4B) , duration of mechanical ventilation (Fig. 4C) , and duration of ICP catheter in situ (102 hr [76.5-127.5 hr] vs 134 hr [100-168 hr]; log rank p = 0.041) were also significantly less in the CPP group as compared with the ICP group. The rise in CPP and fall in ICP, both in terms of overall magnitude and change from baseline over 72 hours, were significantly more in CPP group as compared with ICP group (Figs. 5 and 6) . The mean ICP was significantly lower and CPP higher in survivors as compared with nonsurvivors (Fig. 7, A  and B) . The patients that survived achieved the ICP or CPP target with the respective strategy within the first 24 hours, whereas nonsurvivors failed to respond to ICP or CPP strategy in the first 24 hours (Fig. 7, A and B) . The survivors from ICP group during first 48 hours exhibited a level of CPP around 50-55 mm Hg, which was apparently similar to nonsurvivors in the CPP group. However, the ICP group survivors did not have wide fluctuations in CPP that were seen in the CPP group nonsurvivors.
At the time of discharge from PICU and at 90-day follow-up, significantly lower proportion of patients in CPP group had neurodisability as compared with ICP group (Table 3) Composite poor outcome defined as severe neurodisability or death. All data are presented as number of patients with the specified outcome/total number of patients followed and percentage in parentheses. Neurodisability grading: Mild neurodisability (Pediatric Cerebral Performance Category [PCPC] score 2: conscious, alert, and able to interact at age-appropriate level, but grade perhaps not appropriate for age due to possibility of mild neurologic deficit), moderate neurodisability (PCPC score 3: conscious, sufficient cerebral function for age-appropriate independent activities of daily life, school-age child attending special education classroom, and/or learning deficit present), and severe neurodisability (PCPC score 4: conscious, dependent on others for daily support because of impaired brain function).
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August 2014 • Volume 42 • Number 8 55, 27.3%) was less than half of that in ICP group (33 of 55, 60%) (RR = 0.55; 95% CI, 0.38-0.79; p ≤ 0.001) ( Table 3) .
Adverse Events
No technical complication was encountered during insertion of ICP monitoring catheter. Two patients underwent intraventricular pressure monitoring because of evolving hydrocephalus after 3 days of initial intraparenchymal monitoring. Both patients died, one of them after developing ventriculitis.
DISCUSSION
CPP-targeted therapy as compared with ICP-targeted therapy was associated with significantly lower 90-day mortality, improved coma scores at 72 hours, reduced duration of coma and length of PICU stay, and lower hearing deficit and neurodisability on follow-up at 90 days after PICU discharge. All-cause "in PICU" mortality and total mortality at 90-day follow-up in CPP group were half that of ICP group. Number needed to treat (95% CI) for reduction in 90-day mortality was 6 (2.7-27.7). These results demonstrate superiority of CPP-targeted management of raised ICP over the conventional ICP-targeted therapy in children with acute CNS infections. Our findings are in line with to those of Rosner et al (26) in adults and those of Prabhakaran et al (27) in children with TBI. Rosner et al (26) showed that ICP decreased as CPP increased, and CPP-targeted therapy lowered the mortality rate and improved functional outcome across all GCS score categories in patients with TBI. These results are also similar to our pilot study, which revealed that maintaining a CPP more than 50 mm Hg was associated with a decrease in ICP and 65% survival, even when patients had ICP exceeding 40 mm Hg (7). Prabhakaran et al (27) reported less disability (41.7%) and better intact survival (33.3%) with CPPtargeted treatment as compared with ICP-targeted treatment (80% and none, respectively). However, small sample size was a limiting factor in their study. Our study also confirms the findings of nonrandomized trials in acute CNS infections (21). Lindvall et al (21) used a broad range of measures and unconventional volume target (Lund concept) to manage increased ICP (≥ 15 mm Hg) in 15 children, 45 days to 13 years old, with acute bacterial meningitis; 10 of 15 patients survived and five patients (33%) died; mean ICP was significantly higher and CPP markedly lower among nonsurvivors as compared with survivors. We found that CPP-targeted treatment brought remarkable benefit to patients with acute meningitis, 90-day mortality in CPP group being just one fourth of that in ICP group (10% vs 41%). The benefit of CPP-targeted treatment in acute encephalitis was not of a similar magnitude (Appendix 5, Supplemental Digital Content 5, http://links.lww.com/CCM/ A897; and Appendix 6, Supplemental Digital Content 6, http:// links.lww.com/CCM/A898). However, our sample size was not adequately powered to comment on outcome in subgroups. Possibly diffuse primary brain injury caused by direct invasion of brain in acute encephalitis explains lower benefit from CPP-targeted therapy. Maintaining CPP is effective in prevention of secondary brain injury (5, 21) but is unlikely to reverse primary brain injury.
Significantly greater use of hyperventilation and osmotherapy in ICP group as compared with CPP group was similar to the difference in treatments delivered in management of raised ICP in other studies (27, 35) . Although these differences reflect the difference in approach to control raised ICP, these may affect the outcome adversely.
Hyperventilation decreases ICP by reducing cerebral blood flow and cerebral vasoconstriction (39) . Prolonged hyperventilation may precipitate ischemic lesion in particular areas with low cerebral blood flow (39) . Significantly lower number of ICP spikes that required hyperventilation and lower cumulative duration of hyperventilation in CPP group as compared with ICP group were possibly protective.
The physiological basis for the CPP-targeted therapy is preservation of cerebral autoregulation (26, 27) . Clinically, it is illustrated by a fall in ICP that occurs following an improvement in CPP and a progressively increase in ICP if CPP is inadequate. Autoregulation that is likely to be intact in children with CNS infection finds support in findings by Ashwal et al (40) in 20 children with acute bacterial meningitis over MABP range of 56-102 mm Hg. However, in adult patients, it is impaired in the early phase of acute bacterial meningitis (41) . Autoregulation was apparently unaffected in our patients. They showed a pressure stable relationship between MABP and ICP. Optimization of CPP, therefore, could be expected to bring down raised ICP in our patients by autoregulating cerebral blood flow (CBF). The patients in whom raised ICP failed to respond (did not fall below 20 mm Hg) to ICP or CPP strategy during the first 24 hours, ICP worsened further with a corresponding fall in CPP over the next 48 hours. The patients that achieved the ICP or CPP target with the respective strategy within the first 24 hours were likely to survive. Together, these observations are also of prognostic indicators of PICU outcomes.
Prabhakaran et al (27) demonstrated an effect known as "hysteresis" in the setting of TBI. The basis of this effect is that an injured brain requires higher CPP than the normal brain to achieve a relatively normal CBF because of an increase in cerebrovascular resistance. As a result, the critical closing pressures and lower autoregulatory limit are raised. Prabhakaran et al (27) were able to achieve a mean CPP of 75 mm Hg. We did not achieve such supranormal CPP (mean CPP in CPP group 68 mm Hg and ICP group 52 mm Hg). This is possibly related to the diffuse nature of brain swelling and differences in underlying mechanisms of raised ICP in TBI and acute CNS infections (7). We did not find the presence of hysteresis in our patients, indicating that the lower autoregulatory limit remained unchanged in setting of acute CNS infections.
The main difference in treatment between the two groups was related to use of vasopressors and osmotherapy. Hyperventilation was used to control sudden acute rise (spike) in ICP in both the groups. Fluid boluses and vasopressor were main interventions to achieve higher MABP. Fluid restriction to two thirds of normal maintenance was practiced during first 2-3 days of treatment in patients with bacterial meningitis, with the hope that it reduces cerebral edema, presumably aggravated by syndrome of inappropriate secretion of antidiuretic hormone. The evidence that increased antidiuretic hormone level is an "appropriate" response in bacterial meningitis (42) and fluid restriction does not improve the outcome of acute meningitis (43) has changed the practice to favor maintenance plus replacement fluids aimed at maintaining normovolemia and adequate blood pressure (43, 44).
We, therefore, used these strategies to achieve adequate cerebral perfusion.
Intraparenchymal monitoring was used in our study for its accuracy in the measurement of ICP, ease of insertion at the bedside, safety profile, and low maintenance requirements (45). We did not encounter any technical difficulties and complications related to intraparenchymal ICP catheter. Ventricular catheter was available but rarely used, even though it offers the inherently useful therapeutic option of draining CSF. Need for blind cannulation of the intraventricular system, which is almost impossible in cases of acute CNS infections due to cerebral edema and chinked ventricles, was a major disadvantage of this method. Being a fluid-filled catheter, ventricular catheter also has an inherent possibility of getting blocked with debris and risk of infection particularly after 5 days of monitoring (45, 46) . Both patients in whom ventricular catheter was used died, one of them after developing ventriculitis. Our experience confirms safety and ease of use of intraparenchymal ICP catheter.
Ours is the first prospective randomized study comparing CPP-targeted treatment with ICP-targeted treatment for treating raised ICP in pediatric acute CNS infections.
The study being open labeled was a limitation but that was unavoidable given the nature of study. Cranial CT scans were available for 94 patients (ICP group, 44; CPP group, 50) and only 80 of them (ICP group, 41; CPP group, 39) showed cerebral edema on CT scan. However, CT scan is not a highly reliable tool to confirm the presence of raised ICP (47) . Not all the patients who had cerebral edema on cranial CT scan had an opening ICP more than 20 mm Hg and vice versa (47) . In our patients also, eight (10%) who had cerebral edema on cranial CT scan had an opening ICP less than 20 mm Hg and 11 (11.7%) having normal cranial CT scan had an opening ICP more than 20 mm Hg.
In conclusion, this study shows that CPP-targeted therapy, which relied on more frequent use of vasopressors and lesser use of osmotherapy and hyperventilation, was superior to ICP-targeted therapy for management of raised ICP in children with acute CNS infection, especially acute meningitis, in reducing mortality and morbidity. Future studies, preferably Figure 6 . A, Changes in mean arterial blood pressure (MABP) from baseline to first 72 hr of study period in the two study groups. Mean (± sem) MABP in cerebral perfusion pressure (CPP) group was 3 ± 1.6 and in intracranial pressure (ICP) group -5 ± 1.6 (p = 0.001). b, Changes in ICP from baseline to first 72 hr of study period in the two study groups. Mean (± sem) ICP in CPP group was -15 ± 1.2 and in ICP group -9 ± 1.2 (p = 0.003). C, Changes in CPP from baseline to first 72 hr of study period in the two study groups. Mean (± sem) CPP in CPP group was 18 ± 1.8 and in ICP group 4 ± 1.9 (p ≤ 0.001). Figure 7 . A, Trend of intracranial pressure (ICP) among the survivor and nonsurvivor during first 72 hr of the study period in the two study groups. Mean (± sem) ICP among survivor (cerebral perfusion pressure [CPP] group, 13 ± 5.2 mm Hg and ICP group, 19 ± 1.2 mm Hg) was significantly lower than nonsurvivors (CPP group, 27 ± 3.1 mm Hg and ICP group, 35 ± 1.8 mm Hg) (p ≤ 0.001). b, Trend of CPP among the survivor and nonsurvivors during first 72 hr of the study period in the two study groups. Mean (± sem) CPP among survivor (CPP group, 71 ± 1 mm Hg and ICP group, 55 ± 1.2 mm Hg) was significantly higher than nonsurvivors (CPP group, 53 ± 3.1 mm Hg and ICP group, 45 ± 1.9 mm Hg) (p ≤ 0.001).
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August 2014 • Volume 42 • Number 8 multicentric, should focus on children with different etiologies of acute CNS infections causing raised ICP. In addition, a more detailed evaluation of the temporal profile of the patient's response to treatment and possible adverse effects should be obtained. Performing a multicenter trial, however, may be difficult given the increasing emphasis on support of CPP-targeted approach as standard of care.
